Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Bernard Leick, M.D.

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive25202415102.540 Why?
Receptors, Antigen, T-Cell7202425700.930 Why?
Hematologic Neoplasms5202419270.910 Why?
Graft vs Host Disease3202230780.870 Why?
Pulmonary Alveolar Proteinosis12022410.780 Why?
Hematopoietic Stem Cell Transplantation6202457530.680 Why?
Hematologic Diseases220235000.660 Why?
Communication Barriers120204180.550 Why?
Professional-Family Relations120205010.520 Why?
Leukemia, Myeloid, Acute3202236460.500 Why?
Lymphoma, B-Cell120209430.440 Why?
fms-Like Tyrosine Kinase 3120174970.430 Why?
T-Lymphocytes182024102610.430 Why?
Neurotoxicity Syndromes220233020.300 Why?
Lymphohistiocytosis, Hemophagocytic220232720.290 Why?
Physician-Patient Relations1202032780.270 Why?
Glioblastoma4202434590.260 Why?
Communication1202039160.260 Why?
Molecular Targeted Therapy1201728220.250 Why?
Bone Marrow Transplantation2202427290.230 Why?
Interleukin-7120231470.210 Why?
Transplantation Conditioning2202016350.210 Why?
B-Cell Maturation Antigen120241480.200 Why?
GPI-Linked Proteins120244720.200 Why?
Central Nervous System Neoplasms220229160.200 Why?
Lymphoma2202218970.190 Why?
Xenograft Model Antitumor Assays3202436080.180 Why?
Protein Kinase Inhibitors1201756960.180 Why?
Endopeptidases120247590.170 Why?
Interleukin 1 Receptor Antagonist Protein120222970.170 Why?
Hospital Departments120201350.170 Why?
Translating120201440.160 Why?
Antineoplastic Agents22023136480.160 Why?
Pancytopenia120191010.150 Why?
Humans3820247659680.150 Why?
Cyclophosphamide2202322280.150 Why?
Transduction, Genetic120208980.140 Why?
Proto-Oncogene Proteins c-bcl-21202414100.140 Why?
Lymphoma, T-Cell, Cutaneous120191960.140 Why?
Lentivirus120205180.140 Why?
Neoplasms32023223400.140 Why?
Antigen-Presenting Cells120209620.140 Why?
Telephone120206270.140 Why?
Antibodies, Bispecific120192030.130 Why?
Tandem Repeat Sequences120171840.130 Why?
Multiple Myeloma2202451970.130 Why?
Antigens, Neoplasm2202420020.130 Why?
Sulfonamides1202419840.110 Why?
Ubiquitin-Protein Ligases1202318920.110 Why?
Lymphoma, Non-Hodgkin1202113760.110 Why?
Gene Expression Regulation, Leukemic120176570.110 Why?
Autoantibodies1202221130.110 Why?
Drug Approval120208180.110 Why?
Flow Cytometry1202458810.110 Why?
Biological Products120229420.100 Why?
Lymphoma, Large B-Cell, Diffuse1202214340.100 Why?
United States Food and Drug Administration1202016720.100 Why?
Organoplatinum Compounds120124040.090 Why?
Hodgkin Disease1201913830.090 Why?
Tumor Microenvironment1202439460.090 Why?
Antigens, CD19220224430.080 Why?
Apoptosis1202495140.070 Why?
Intensive Care Units1202038000.070 Why?
Cell Line, Tumor42024170750.070 Why?
Pancreatic Neoplasms1202454440.070 Why?
Skin1201944890.060 Why?
Antibodies, Monoclonal1202392490.060 Why?
Neoplasm Staging12020112060.060 Why?
Combined Modality Therapy1201785290.060 Why?
Antigens, CD712024300.060 Why?
Antineoplastic Combined Chemotherapy Protocols22017118680.060 Why?
Disease Progression12020136320.050 Why?
Cytokines3202374210.050 Why?
bcl-X Protein120244140.050 Why?
Bone Marrow2202429210.050 Why?
Drug Resistance, Neoplasm1201753370.050 Why?
France120234950.050 Why?
Clinical Trials as Topic1201780410.050 Why?
Antibodies, Viral2202232110.040 Why?
Transgenes1202410150.040 Why?
Adult720242230440.040 Why?
Ubiquitination120239960.040 Why?
Macrophage Activation120225520.040 Why?
Serine Endopeptidases1202410240.040 Why?
Mice52024818190.040 Why?
Brain Neoplasms1201990710.040 Why?
Codon, Nonsense120192880.040 Why?
Liver Neoplasms1201243530.030 Why?
Cell Death1202216790.030 Why?
United States22023729030.030 Why?
Transforming Growth Factor beta1202319950.030 Why?
Leukocytes, Mononuclear1202218570.030 Why?
Fatal Outcome1201918310.030 Why?
Exanthema120195020.030 Why?
Neoplasm Recurrence, Local2202493730.030 Why?
Child22023805640.030 Why?
Tissue Donors1202423950.030 Why?
Neoplasms, Experimental1201912290.030 Why?
Treatment Outcome22019651880.030 Why?
Signal Transduction12017236010.030 Why?
Antigens, CD1202440250.030 Why?
Retrospective Studies22019815140.030 Why?
Animals520241687640.030 Why?
Interferon-gamma1202231600.030 Why?
Carcinoma, Pancreatic Ductal1202417580.030 Why?
Middle Aged620242230090.030 Why?
Mutation12017301980.030 Why?
Infusions, Intra-Arterial120122180.020 Why?
Fever1201916030.020 Why?
Recurrence1202485010.020 Why?
Proto-Oncogene Proteins1202445200.020 Why?
Peptide Fragments1202451250.020 Why?
Hepatic Artery120122310.020 Why?
Aged520241711170.020 Why?
CD8-Positive T-Lymphocytes1202446420.020 Why?
Vaccination1202234260.020 Why?
Male620243636980.020 Why?
Biopsy1201967630.020 Why?
Membrane Proteins1202478510.020 Why?
Adenocarcinoma1202463640.020 Why?
Cognition1202370490.020 Why?
Female520243961120.020 Why?
Incidence12023214800.020 Why?
Diagnosis, Differential12019129760.010 Why?
Cell Differentiation12019116410.010 Why?
Risk Factors12024748400.010 Why?
Young Adult12019598890.010 Why?
Adolescent12019888350.010 Why?
Aged, 80 and over12012594890.000 Why?
Leick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (75)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.